GENERAL, O. Reg. 256/24
Section 51
Prescribing
Cite as GENERAL, O. Reg. 256/24, s. 51 · current to November 11, 2026 · consolidated from September 30, 2026 · read from e-Laws on November 16, 2026
The text
(1) For the purposes of paragraph 3 of subsection 4 (1) of the Act, a Part A pharmacist is authorized to prescribe the following drugs, subject to subsections (2) and (4) of this section and to the terms, conditions and limitations imposed on their certificate of registration:
1. For the sole purpose of smoking cessation, the following specified drugs:
i. Bupropion Hydrochloride.
ii. Varenicline Tartrate.
2. For the sole purpose of treating a minor ailment listed in Column 1 of the Table to Schedule 4, a drug opposite the minor ailment in Column 3 of that Table.
3. For the sole purpose of treating COVID-19, Nirmatrelvir/Ritonavir.
4. For the sole purpose of treating influenza, Oseltamivir.
(2) In the case of drug referred to in paragraph 3 of subsection (1),
(a) the Part A pharmacist shall make a determination as to the patient’s risk for any drug interactions that cannot be properly managed or that prevent Nirmatrelvir/Ritonavir from being prescribed and shall not prescribe the drug if such an interaction exists; and
(b) the Part A pharmacist shall notify the patient’s primary care provider, if any, within a reasonable time that the pharmacist prescribed Nirmatrelvir/Ritonavir to the patient and provide details respecting the prescription.
(3) For the purposes of paragraph 3 of subsection 4 (1) of the Act, an intern is authorized to prescribe the following drugs, subject to subsection (4) of this section and to the terms, conditions and limitations imposed on their certificate of registration:
1. For the sole purpose of smoking cessation, the following specified drugs:
i. Bupropion Hydrochloride.
ii. Varenicline Tartrate.
2. For the sole purpose of treating a minor ailment listed in Column 1 of the Table to Schedule 4, a drug opposite the minor ailment in Column 3 of that Table.
(4) A Part A pharmacist or an intern may only prescribe a drug under this section if they,
(a) possess sufficient knowledge, skill and judgment respecting the drug and the patient’s condition to prescribe the drug for the patient;
(b) have considered whether prescribing the drug for the patient is appropriate, given the known risks and benefits of prescribing the drug for the patient and other relevant factors respecting the patient;
(c) give the prescription to the patient or the patient’s authorized agent;
(d) advise the patient or the patient’s authorized agent, at the time of giving the prescription, that they may elect to take it to a pharmacy of their choosing for dispensing;
(e) notify the patient’s primary care provider, if any, within a reasonable time, that the Part A pharmacist or intern prescribed a drug for the patient and provide details respecting the prescription;
(f) comply with the additional requirements under sections 53 and 54; and
(g) have determined, through a therapeutic assessment, that the drug is the most appropriate treatment for the patient’s condition.
Read the GENERAL on e-Laws ↗
Made under Pharmacy Act, 1991, S.O. 1991, c. 36.